Audi E A, de Aguiar J C, Graeff F G
Department of Pharmacology, FMRP and Laboratory of Psychobiology, FFCLRP, Campus of the University of São Paulo, Ribeirão Preto, SP, Brazil.
J Psychopharmacol. 1988 Jan;2(1):26-32. doi: 10.1177/026988118800200105.
Previously reported results indicate that serotonin (5-HT) inhibits the neural sub strate of aversion in the dorsal midbrain central grey (DCG) of the rat. In addition, the present results show that microinjection of the 5-HT uptake inhibitor zimelidine (100 nmol) into the DCG of rats with chronically implanted chemitrodes raised the threshold of aversive electrical stimulation. This antiaversive effect of zimelidine was antagonized by pretreatment with the 5-HT(2) receptor blocker ritanserin (10 nmol), also microinjected into the DCG. In contrast, the antiaversive effect of the benzodiazepine agonist midazolam (40 nmol) was unaffected by ritanserin. Propranolol (2.2, 4.4 and 8.8 nmol) raised the aversive threshold in a dose-depen dent way following its injection into the DCG. The antiaversive effect of 4.4 nmol of propranolol was antagonized by previous administration of ritanserin (10 nmol). Moreover, combined administration of zimelidine (100 nmol) followed by propranolol (4.4 nmol) caused an anti aversive effect which was equivalent to the sum of the effect of each drug alone. These results indicate that the antiaversive effect of intracerebrally injected zimelidine and propranolol is mediated by endogenous 5-HT, through activation of 5-HT(2) receptors.
先前报道的结果表明,血清素(5-羟色胺,5-HT)可抑制大鼠中脑背侧中央灰质(DCG)的厌恶神经基质。此外,目前的结果显示,向长期植入化学微电极的大鼠DCG中微量注射5-HT摄取抑制剂齐美利定(100纳摩尔)可提高厌恶电刺激的阈值。齐美利定的这种抗厌恶作用可被同样微量注射到DCG中的5-HT(2)受体阻滞剂利坦色林(10纳摩尔)预处理所拮抗。相比之下,苯二氮䓬类激动剂咪达唑仑(40纳摩尔)的抗厌恶作用不受利坦色林影响。普萘洛尔(2.2、4.4和8.8纳摩尔)注射到DCG后,以剂量依赖方式提高了厌恶阈值。4.4纳摩尔普萘洛尔的抗厌恶作用可被先前给予的利坦色林(10纳摩尔)所拮抗。此外,先注射齐美利定(100纳摩尔),随后注射普萘洛尔(4.4纳摩尔),联合用药产生的抗厌恶作用相当于每种药物单独作用效果之和。这些结果表明,脑内注射齐美利定和普萘洛尔的抗厌恶作用是由内源性5-HT通过激活5-HT(2)受体介导的。